Design Development and Characterization of Biosensors and Nanoparticulate Carriers for Renal Cell Carcinoma

dc.contributor.guideShende Pravin
dc.coverage.spatiali-x;791
dc.creator.researcherTakke Anjali
dc.date.accessioned2023-03-09T05:10:30Z
dc.date.available2023-03-09T05:10:30Z
dc.date.awarded2022
dc.date.completed2022
dc.date.registered2018
dc.description.abstractMagnetic-core-based silibinin nanopolymeric carriers for the treatment of renal cell cancer.The synthesized iron oxide nanoparticles were prepared by precipitation method via encapsulation of silibinin in PLGA network using double emulsion method. The nanoparticle formulations were characterized for morphological, physicochemical properties (HRTEM, FTIR, Raman Spectroscopy and VSM), in-vitro drug release and cytotoxicity study on kidney cancer cells (A-498). The safety of magnetic-core-based silibinin nanopolymeric carriers was conducted byi.v. administration at a dose of 50 mg/kg in mice. newlineMagnetic-core-based silibinin nanopolymeric carriers were prepared with the double emulsion solvent evaporation method for the treatment of renal cell cancer. The newly developed drug delivery system possessed an acceptable particle size, zeta potential and high % EE with a greater inhibitory effect on the growth of kidney cancer cells (A-498)as compared to free silibinin. Stability studies indicated that the storage of SLB-MPNPs at refrigerated conditions increases the stability of the formulation for a period of 3 months. Acute toxicity study revealed that SLB-MPNPs were found to be safe at a dose of 50 mg/kg for administration in mice. Silibinin is a clinically accepted herbal drug with minimum side effects, therefore the magnetic-core-based silibinin nanopolymeric carriers considered as an effective targeted drug delivery system for treating renal cell cancer. newlineMonodispersed magnetographene quantum dot nanocomposites for delivery of silibinin newlineSilibinin shows multi-applications and therapeutic activities such as anticancer, antioxidant, hypocholesterolemic, cardioprotective, neuroprotective and hepatoprotective but exhibits limited clinical applications due to poor oral bioavailability and in-vitro in-vivo biological correlation. The present study focused on the characterization of magnetic graphene quantum dot nanocomposites for silibinin delivery with a specific interest in kidney cancer treatment..
dc.description.note
dc.format.accompanyingmaterialDVD
dc.format.dimensions
dc.format.extenti-x;791
dc.identifier.urihttp://hdl.handle.net/10603/466907
dc.languageEnglish
dc.publisher.institutionDepartment of Pharmacy
dc.publisher.placeMumbai
dc.publisher.universityNarsee Monjee Institute of Management Studies
dc.relation
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordClinical Pre Clinical and Health
dc.subject.keywordMagnetic-core-based silibinin nanopolymeric carriers, renal cell cancer
dc.subject.keywordPharmacology and Pharmacy
dc.subject.keywordPharmacology and Toxicology
dc.titleDesign Development and Characterization of Biosensors and Nanoparticulate Carriers for Renal Cell Carcinoma
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 12
Loading...
Thumbnail Image
Name:
01_ title.pdf
Size:
200.94 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02_prelim pages.pdf
Size:
643.42 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03_content.pdf
Size:
9.77 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
04_abstract.pdf
Size:
115.41 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05_chapter 1.pdf
Size:
1.4 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: